Because the majority of HBsAg−ve HBV DNA+ve (“occult”) participants did not differ from HBsAg+ve HBV DNA+ve (overt) participants in terms of viral loads, CD4 counts, ALT levels and frequency of liver fibrosis, it may be more accurate to refer to these HBV infections as HBsAg-covert (HBsAg-cryptic overt) instead of false “occult” [19]. This evidence concerns the gene GPT and Hepatic fibrosis.